Mary Jo Wildey
-
- Microbial Natural Products and Biosynthesis 4
- Fungal Biology and Applications 3
-
- Computational Drug Discovery Methods 3
-
- Metabolomics and Mass Spectrometry Studies 2
- Fibroblast Growth Factor Research 2
- Receptor Mechanisms and Signaling 2
-
- Tannin, Tannase and Anticancer Activities 2
-
- Adenosine and Purinergic Signaling 2
- Co-authors
- William M. MaieseN. A. KUCKMichael GreensteinMary P. LechevalierHubert A. LechevalierJ. D. KORSHALLAWeimin TangJoseph J. Goodman
- Partner nations
- United StatesNetherlandsIsrael
In The Last Decade
Mary Jo Wildey
22 papers receiving 265 citations
Peers
Comparison fields: 5 of 73
- Pharmacology 69
- Toxicology 11
- Molecular Medicine 14
- Biophysics 16
- Spectroscopy 39
Countries citing papers authored by Mary Jo Wildey
This map shows the geographic impact of Mary Jo Wildey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Jo Wildey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Jo Wildey more than expected).
Fields of papers citing papers by Mary Jo Wildey
This network shows the impact of papers produced by Mary Jo Wildey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Jo Wildey. The network helps show where Mary Jo Wildey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary Jo Wildey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2021 | 30 | |
| 3 | 2020 | 5 | |
| 4 | 2020 | 4 | |
| 5 | Microplate Selection and Recommended Practices in High-throughput Screening and Quantitative Biology | 2020 | 14 |
| 6 | 2019 | 4 | |
| 7 | Chapter Five - High-Throughput Screening | 2017 | 3 |
| 8 | 2015 | 12 | |
| 9 | 2010 | 17 | |
| 10 | 2004 | 7 | |
| 11 | 2003 | 2 | |
| 12 | 2003 | 8 | |
| 13 | 2001 | 4 | |
| 14 | 1999 | 10 | |
| 15 | 1999 | 1 | |
| 16 | 1996 | 20 | |
| 17 | 1990 | 15 | |
| 18 | 1989 | 24 | |
| 19 | 1989 | 6 | |
| 20 | 1989 | 75 |
About Mary Jo Wildey
Mary Jo Wildey is a scholar working on Applied Microbiology and Biotechnology, Physiology and Pharmacology, having authored 23 papers that have together received 293 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (4 papers), Computational Drug Discovery Methods (3 papers), Fungal Biology and Applications (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Fibroblast Growth Factor Research (2 papers), Tannin, Tannase and Anticancer Activities (2 papers), Adenosine and Purinergic Signaling (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Pharmacology (69 citations), Toxicology (11 citations) and Molecular Medicine (14 citations). Mary Jo Wildey has collaborated with scholars based in United States, Netherlands and Israel. Frequent co-authors include William M. Maiese, N. A. KUCK, Michael Greenstein, Mary P. Lechevalier, Hubert A. Lechevalier, J. D. KORSHALLA, Weimin Tang, Joseph J. Goodman, Johannes Voigt and Robert P. Sheridan.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.